Abstract:Ondansetron tablets that are directly compressed using crospovidone and croscarmellose as a synthetic super disintegrant are the subject of this investigation. A central composite, response surface, randomly quadratic, nonblock (version 13.0.9.0) 32 factorial design is used to optimize the formulation (two-factor three-level). To make things even more complicated, nine different formulation batches (designated as F1–F9) were created. There were three levels of crospovidone and croscarmellose (+1, 0, -1). In addition to that, pre- and postcompressional parameters were evaluated, and all evaluated parameters were found to be within acceptable range. Among all postcompressional parameter dispersion and disintegration time, in vitro drug release experiments (to quantify the amount of medication released from the tablet) and their percentage prediction error were shown to have a significant influence on three dependent variables. Various pre- and postcompression characteristics of each active component were tested in vitro. Bulk density, tap density, angle of repose, Carr's index, and the Hausner ratio were all included in this analysis, as were many others. This tablet's hardness and friability were also assessed along with its dimension and weight variations. Additional stability studies may be conducted using the best batch of the product. For this study, we utilised the Design-Expert software to select the formulation F6, which had dispersion times of 17.67 ± 0.03 seconds, disintegration times of 120.12 ± 0.55 seconds, and percentage drug release measurements of 99.25 ± 0.36 within 30 minutes. Predicted values and experimental data had a strong correlation. Fast dissolving pills of ondansetron hydrochloride may be created by compressing the tablets directly.

Preparation of Ondansetron Hydrochloride Sustained-release Tablet Evaluation of Its and Drug Release Behavior in Vitro

Study on pramipexole dihydrochloride sustained-release tablets

Preparation of Ondansetron Hydrochloride Orally Disintegrating Tablets

Preparation of Levodropropizine Sustained Release Matrix Tablet and Its in Vitro Evaluation of Drug Release

Preparation of Venlafaxine Hydrochloride Matrix Tablets and Study of Release Behavior in Vitro

Preparation and characterization of fast-release oral film formulation containing ondansetron hydrochloride solid dispersion

Preparation of Venlafaxine Hydrochloride Sustained-release Tablets and Release Behavior in Vitro

Preparation of Zhitong Sustained-Release Tablet and Its Release Property in Vitro

Study on Formulation and Preparation Procedure of Erythromycin Ethylsuccinate Sustained-release Tablets and Their Influence on Drug Release

Preparation of matrix tablet of metronidazole and evaluation of controlled-release

Evaluation of Carbopol 71G and HPMC As Matrix Materials in a Sustained Release Formulation

Preparation of Compound Anisodamine and Neostigmine Sustained-release Tablet and Study on the in vitro Drug Release Behavior

[Preparation of Diltiazem Hydrochloride Delayed-Onset, Sustained Release Tablet].

Preparation and in vitro Release of Doxazosin Mesylate Controlled-Release Tablets

Studies on Sustained Release Hydrophilic Matrix Tablets Containing Hydroxypropylmethylceilulose and Carbopol

Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride

Study of Pseudoephedrine Hydrochloride Sustained-release Preparations and Its Release in vitro

Preparation and In-Vitro Release of Metformin Hydrochloride Sustained-Release Pellets

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets

Preparation of Omeprazole Gastric Immediate Release Tablets and Study on the Formulation Thereof

Preparation and in Vitro Release Study of Sodium Ferulate Gastric Floating Tablets